Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing and Disclosure Requirements) Regulations, 2015, as amended ,(''Listing Obligations''), read with para A ....

Earkart Ltd has announced the incorporation of its new foreign subsidiary, Earkart Health Limited, in the United Kingdom on June 8, 2026. Earkart holds a 65% stake in the new entity, which has a paid-up share capital of GBP 10,000, with Earkart investing GBP 6,500. The subsidiary's objective is to provide healthcare services and sell related products, aligning with Earkart's main line of business. This strategic move signals international expansion into the UK healthcare market. Being newly formed, it currently has no turnover.